WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial — adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic

WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial — adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic

Abstract Background As a pragmatic randomised timing-of-birth trial, WILL adapted its trial procedures in response to the COVID-19 pandemic. These are reviewed here to inform post-pandemic trial methodology. Methods The trial (internal pilot) paused in March 2020, re-opened in July 2020, and is curr...

Full description

Bibliographic Details
Main Authors: Laura A. Magee, Sue Tohill, Katie Kirkham, Ruth Evans, Eleni Gkini, Catherine A. Moakes, Clive Stubbs, Jim Thornton, Peter von Dadelszen, the WILL Trial Study Group
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Trials
Subjects:
Trial management
Remote consent
COVID
Pregnancy
Timing of birth
Online Access:https://doi.org/10.1186/s13063-022-06834-4

Internet

https://doi.org/10.1186/s13063-022-06834-4

Similar Items